scispace - formally typeset
M

Mamadu Baldeh

Researcher at University of Sierra Leone

Publications -  5
Citations -  34

Mamadu Baldeh is an academic researcher from University of Sierra Leone. The author has contributed to research in topics: Sierra leone & Medicine. The author has an hindex of 1, co-authored 3 publications receiving 10 citations.

Papers
More filters
Journal ArticleDOI

Prevalence and mortality of cryptococcal disease in adults with advanced HIV in an urban tertiary hospital in Sierra Leone: a prospective study.

TL;DR: The high mortality suggests a need for the HIV programme to formulate and implement policies on screening and pre-emptive fluconazole therapy for all adults with advanced HIV in Sierra Leone, and advocate for affordable access to effective antifungal therapies.
Journal ArticleDOI

Impact of COVID-19 on Tuberculosis Case Detection and Treatment Outcomes in Sierra Leone.

TL;DR: In this article, the authors conducted a retrospective study to assess the impact of the COVID-19 pandemic on TB case detection and treatment outcomes at the Chest Clinic at Connaught Hospital in Freetown, Sierra Leone.
Journal ArticleDOI

Stroke in Sierra Leone: Case fatality rate and functional outcome after stroke in Freetown

TL;DR: In this article , the authors report the long-term outcomes after stroke in sub-Saharan Africa (SSA) and describe factors associated with mortality and functional outcome, using a large, prospective, longitudinal cohort of stroke patients in Sierra Leone.
Posted ContentDOI

Sepsis and septic shock in COVID-19: a scoping review of the research data

TL;DR: There is a paucity of data in the literature on sepsis in COVID-19 despite its high burden resulting in a high rate of antimicrobial use that is not backed by clearly documented microbiology laboratory support.
Journal ArticleDOI

All-cause mortality of hospitalised patients with suspected COVID-19 in Sierra Leone: a prospective cohort study

TL;DR: In this article , the authors explored the factors associated with mortality during the COVID-19 pandemic and highlighted the complexities of treating patients with a novel epidemic disease in a fragile health system.